Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
[68Ga]CBP8
Dotarem
Locations
1
United States
Massachusetts General Hospital
Boston, Massachusetts, United States
Start Date
September 28, 2022
Primary Completion Date
April 1, 2026
Completion Date
April 1, 2026
Last Updated
May 9, 2025
NCT07484243
NCT06992661
NCT07077486
NCT05878717
NCT07300696
NCT06626438
Lead Sponsor
Massachusetts General Hospital
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions